Haryana Stops Production of ‘Contaminated’ Cough Syrups by Maiden Pharmaceuticals

The Haryana government on Wednesday directed the Sonepat based Maiden Pharmaceuticals Limited to stop production of the contaminated cough syrups.

Written by: India.com News Desk Edited by: Rajashree Seal

Updated: October 12, 2022, 11:27 AM IST

Share

Share Article

• Facebook
• WhatsApp
• X
• Email
• Telegram
• Linkedin

https://www.india.com/news/india/contaminated-cough-syrups-production-stopped-by-maiden-pharmaceuticals-haryana-govt-promethazine-oral-solution-kofexmalin-baby-makoff-baby-a-5681778/ Copy

A photograph shows collected cough syrups in Banjul on October 06, 2022. Indian authorities are investigating cough syrups made by a local pharmaceutical company after the World Health Organisation said they could be responsible for the deaths of 66 children in The Gambia. (AFP photo)

Gurugram: Nearly a week after the World Health Organization (WHO) issued an alert for four “contaminated” India-made medicines, the Haryana government on Wednesday directed the Sonepat-based Maiden Pharmaceuticals Limited to stop production of the cough syrups.

A WHO Medical Product Alert said that the four substandard products, reported to it in September, are Promethazine Oral Solution, Kofexmalin Baby Cough Syrup, Makoff Baby Cough Syrup, and Magrip N Cold Syrup, all manufactured by the Maiden medical firm. The information from WHO that cough syrups manufactured by an Indian pharma company caused the death of 66 children due to the presence of ethylene glycol is alarming. A probe has been initiated by India’s drug regulator after the WHO alert.

Speaking on the matter, Haryana’s Health Minister Anil Vij said samples of 3 drugs mentioned by WHO of Sonipat’s pharmaceuticals company were sent to Central Drug Lab in Kolkata. The reports are not in yet, action will be taken after that.